Seqirus opens U.K. office; Mitsubishi Tanabe plans U.S. flu vaccine;

> CSL's flu vaccine unit Seqirus opened a U.K. corporate office. Release

> Japan's Mitsubishi Tanabe Pharma plans to focus on increasing its U.S. sales, with one component of its strategy involving a flu vaccine currently under development. Report

> A paper in PLOS Medicine argues in favor of a compensation system for vaccine injuries for cases such as the Ebola outbreak in which vaccines must be tested rapidly without hesitation due to liability. More

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.